Concepedia

Steven W. Goldstein

SW

Statistics

Publications

25

Citations

872

H-Index

17

Active since

1967

Affiliations

Pfizer (United States)(Current)

University of Saint Joseph

University at Buffalo, State University of New York

Steven W. Goldstein is an author at Pfizer (United States) specializing in chemistry, medicinal chemistry, and natural sciences.

ORCID

Publications per year

1967–2017

25

Publications

25

The first enantioselective total syntheses of the allopumiliotoxin A alkaloids 267A and 339B

Steven W. Goldstein, Larry E. Overman, Michael H. Rabinowitz · The Journal of Organic Chemistry · 1992 · 83 citations

, , +7

Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors

Janice D. Pata, William G. Stirtan, Steven W. Goldstein et al. · Proceedings of the National Academy of Sciences · 2004 · 81 citations · Full text

, , +17

Novel thiazolidine-2,4-diones as potent euglycemic agents.

Bernard Hulin, David A. Clark, Steven W. Goldstein et al. · Journal of Medicinal Chemistry · 1992 · 75 citations

, , +17

Synthetic studies of the cyclopropyl iminium ion rearrangement. 3. Application of the cyclopropyl acyliminium ion rearrangement to a concise and highly convergent synthesis of (.+-.)-lycorine

Robert K. Boeckman, Steven W. Goldstein, Michael A. Walters · Journal of the American Chemical Society · 1988 · 69 citations

, , +5

Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents

David A. Clark, Steven W. Goldstein, R. A. VOLKMANN et al. · Journal of Medicinal Chemistry · 1991 · 66 citations

, , +7

1–5 of 25